Price/Volume Surge: StemCells (STEM)

Posted in General 
November 3rd, 2008

StemCells, Inc. (NASDAQ:STEM) is trading sharply higher today after the company reported today that its HuCNS-SC® proprietary product candidate (purified human neural stem cells) can protect the retina from progressive degeneration when transplanted into a well-established animal model.

Shares are up a whopping 43% at $2.06 on heavy trading at 10:30 AM EST.  Average daily volume is about 450,000 and we have already seen 3.2 million shares change hands in just an hour since the open.

Jon Ogg
November 3, 2008

Comments are closed

-->